Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Christopher T. Szlenk"'
Autor:
Sabrina Fechtner, Anil K. Singh, Ila Srivastava, Christopher T. Szlenk, Tim R. Muench, Senthil Natesan, Salahuddin Ahmed
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Management of pain in the treatment of rheumatoid arthritis (RA) is a priority that is not fully addressed by the conventional therapies. In the present study, we evaluated the efficacy of cannabinoid receptor 2 (CB2) agonist JWH-015 using RA synovia
Externí odkaz:
https://doaj.org/article/95384f265754403eba37a156a176735f
Autor:
Jeevan B. GC, Christopher T. Szlenk, Ayobami Diyaolu, Peter Obi, Haiyang Wei, Xutong Shi, K. Michael Gibson, Senthil Natesan, Jean-Baptiste Roullet
Publikováno v:
Biophysical Journal. 122:849-867
Publikováno v:
Molecular Pharmacology. 100:406-427
The drugs salmeterol, formoterol, and salbutamol constitute the frontline treatment of asthma and other chronic pulmonary diseases. These drugs activate the β2-adrenergic receptors (β2-AR), a class A G protein–coupled receptor (GPCR), and differ
Publikováno v:
Curr Protoc Essent Lab Tech
Today’s science is largely funded by taxpayer dollars, and because of this, scientists have a responsibility to ensure that their research is being effectively communicated back to taxpayers and to the policy makers who determine the distribution o
Publikováno v:
Mol Pharm
Resolvins D1 and D2 (RvDs) are structural isomers and metabolites of docosahexaenoic acid, an omega-3 fatty acid, enzymatically produced in our body in response to acute inflammation or microbial invasion. Resolvins have been shown to play an essenti
Publikováno v:
Mol Pharmacol
The ligand-binding sites of many G protein-coupled receptors (GPCRs) are situated around and deeply embedded within the central pocket formed by their seven transmembrane-spanning α-helical domains. Generally, these binding sites are assumed accessi
Autor:
Christopher T. Szlenk, Senthil Natesan
Publikováno v:
The FASEB Journal. 35
Publikováno v:
Mol Pharmacol
The drugs salmeterol, formoterol, and salbutamol constitute the frontline treatment of asthma and other chronic pulmonary diseases. These drugs activate the β2-adrenergic receptors (β2-AR), a class A G protein–coupled receptor (GPCR), and differ
Publikováno v:
The FASEB Journal. 33
Autor:
Jean-Baptiste Roullet, B Gc Jeevan, K. Michael Gibson, Christopher T. Szlenk, Senthil Natesan
Publikováno v:
The FASEB Journal. 33